The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Novartis
Efficacy and safety results from ASCEMBL, a phase 3 study of asciminib versus bosutinib (BOS) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) after ≥2 prior tyrosine kinase inhibitors (TKIs): Week 96 update.
 
Delphine Rea
Consulting or Advisory Role - Incyte; Novartis; Pfizer
 
Michael J. Mauro
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Sun Pharma (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer; Takeda
 
Andreas Hochhaus
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; Pfizer
Research Funding - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Carla Boquimpani
No Relationships to Disclose
 
Elza Lomaia
Leadership - Novartis
Honoraria - Novartis
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Novartis
 
Sergey Voloshin
Honoraria - Novartis
Speakers' Bureau - Novartis
 
Anna G. Turkina
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
 
Dong-Wook Kim
Leadership - Bristol-Myers Squibb; Pfizer
Honoraria - Bristol-Myers Squibb; IL-Yang Pharm; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; IL-Yang Pharm; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; IL-Yang Pharm; Novartis; Pfizer; Sun Pharma; Takeda
 
Jane Apperley
Honoraria - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Incyte; Novartis; Pfizer
Research Funding - Incyte; Pfizer
 
Jorge E. Cortes
Consulting or Advisory Role - Astellas Pharma; Bio-Path Holdings, Inc; Bristol-Myers Squibb; Centessa Pharmaceuticals; Gilead Sciences; Jazz Pharmaceuticals; Menarini; Novartis; Pfizer; Takeda
Research Funding - Abbvie/Genentech (Inst); Actuate Therapeutics (Inst); Astellas Pharma (Inst); Bio-Path Holdings, Inc (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Sellas Life Sciences (Inst); Sun Pharma (Inst); Takeda (Inst)
 
Koji Sasaki
Honoraria - Otsuka
Consulting or Advisory Role - Novartis; Pfizer; Takeda
Research Funding - Novartis
Travel, Accommodations, Expenses - Otsuka
 
Shruti Kapoor
Employment - Novartis
 
Alex Allepuz
Employment - Novartis
 
Sara Quenet
Employment - Novartis
 
Véronique Bédoucha
Employment - Novartis
 
Yosuke Minami
Honoraria - Astellas Amgen BioPharama; Bristol-Myers Squibb; Novartis; Novartis; Pfizer; Takeda